Drawing for DERMACIN

USPTO serial 90090007

DERMACIN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CHANG, ELIZABETH YI HSUAN
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with DERMACIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Medicated hair care preparations; Medicated lotions for treating dermatological conditions; Medicated ointments for treating dermatological conditions; Medicated skin care preparations; Acne medications; Adhesive tapes for medical purposes; Analgesic and muscle relaxant pharmaceutical preparations; Anti-inflammatory gels; Anti-inflammatory salves; Anti-inflammatory sprays; Antibacterial cleaners; Antibacterial spray; Antibiotic ointments; Antibiotic tablets; Burn dressings; Dietary and nutritional supplements; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplements for human consumption; Disinfectants for hygiene purposes; Disinfectants for sanitary purposes; Headache treatment preparations; Medicated balms for treatment of post surgical wound care; Medicated bath preparations; Medicated body powder; Medicated cosmetics; Medicated creams for treating dermatological conditions; Medicated dermatological preparations and substances; Medicated pre-moistened towelettes; Medicated serums for treatment of post surgical wound care; Medicated skin care preparations, namely, creams, lotions, gels, toners, cleaners and peels; Medicated skin preparation for use in treating post surgical wound care; Medicated sun care preparations; Medicated throat sprays; Medicinal preparations for the mouth and as sprays; Mentholated ointment for medical use; Natural herbal supplements; Nutritional supplement for eliminating toxins from the intestinal tract; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, antivirals; Pharmaceutical skin lotions; Prenatal vitamins; Saline solution for medical purposes; Sanitary towels; Sanitizing preparations for hospital use; Sanitizing preparations for use in institutional and industrial areas; Skin lubricants for athletes to prevent skin chafing; Therapeutic agents for weight control and appetite suppression; Therapeutic medicated bath preparations; Therapeutic pharmaceutical for the treatment of post surgical wound care; Vitamin A preparations; Vitamin B preparations; Vitamin C preparations; Vitamin D preparationsACTIVEJan 1, 1996

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Mar 11, 2022MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 11, 2022ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 10, 2022DOCKASSIGNED TO EXAMINER—
Aug 27, 2021GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Aug 27, 2021GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 27, 2021CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 25, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 25, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Feb 25, 2021CNSLSUSPENSION LETTER WRITTEN—
Feb 25, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 25, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 24, 2021ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Feb 3, 2021GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 3, 2021GNSLLETTER OF SUSPENSION E-MAILED—
Feb 3, 2021CNSLSUSPENSION LETTER WRITTEN—
Feb 3, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 3, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 3, 2021ALIEASSIGNED TO LIE—
Oct 27, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 26, 2020DOCKASSIGNED TO EXAMINER—
Sep 1, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 6, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance